Method for enzymatic synthesis of D-leucine
An enzymatic synthesis, leucine technology, applied in the field of enzyme catalysis, can solve the problems of cumbersome product extraction and purification steps, economic unfeasibility, long production cycle, etc., and achieve the effect of good industrial development and application prospects
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0045] Embodiment 1 Construction of wild-type D-amino acid dehydrogenase expression strain
[0046] For the wild-type D-amino acid dehydrogenase SEQ ID NO:1 derived from Ureibacillus thermosphaericus, codon optimization was performed, and the coding gene sequence SEQ ID NO:2 was synthesized from the whole gene, and restrictions were designed at both ends of the gene The endonuclease sites Nde I and XhoI were subcloned into the corresponding sites of the vector pET24a (Novagen) to obtain the recombinant plasmid pET24a-utDAADH. The recombinant plasmid pET24a-utDAADH was transformed into the expression host Escherichia coli BL21(DE3) to obtain the recombinant Escherichia coli utDAADH expressing the wild enzyme.
Embodiment 2
[0047] The construction of embodiment 2 glucose dehydrogenase expression bacterial strain
[0048] For the glucose dehydrogenase SEQ ID NO: 6 derived from Bacillus cereus, the whole gene synthesis coding gene sequence SEQ ID NO: 7, and restriction endonuclease sites Nde I and XhoI were designed at both ends of the gene , subcloned into the corresponding site of the vector pET24a (Novagen) to obtain the recombinant plasmid pET24a-bcGDH. The recombinant plasmid pET24a-bcGDH was transformed into the expression host Escherichia coli BL21(DE3) to obtain the recombinant Escherichia coli bcGDH expressing glucose dehydrogenase.
Embodiment 3
[0049] Embodiment 3 construction (D94A, R199V, H249T) mutant strain
[0050] According to the method reported in Example 3 of patent document CN202110108232.9, construct (D94A, R199V, H249T) mutant SEQ ID NO: 3 expression strains, including the following steps:
[0051] 3.1 Using the plasmid pET24a-utDAADH of the utDAADH strain as a template, aiming at the 94th, 199th, and 249th positions in wild-type D-amino acid dehydrogenation SEQ ID NO: 1, it was transformed into D94A, R199V, H249T, and according to the method in Example 1, a mutant expression strain utDAADH-M containing these three mutations was constructed. The primers used in the construction process are as follows: utDAADH-94F: 5'-CAACACCATCGACTCTTTC GCC ACCCACGCTCGTATC-3', utDAADH-199F: 5'-CTACCCGTGAAAAACACGCTGTTGAATGCTTCGTTGTTC-3', utDAADH-199R: 5'-GAACAACGAAGCATTCAACAGCGTGTTTTTCACGGGTAG-3', utDAADH-249R: 5'-GATAACGAAGCCGCCGGTGGGCATACCAGTG-3'.
[0052] Using the pET24a-utDAADH plasmid as a template and utDAADH-94F...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More - R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com

